{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:25:47Z","timestamp":1792016747104,"version":"4.4.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2019.00100","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T04:47:24Z","timestamp":1556081244000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington\u2019s Disease Pre-clinical Model"],"prefix":"10.3389","volume":"12","author":[{"given":"Alba","family":"Di Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Capocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susy","family":"Giova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Kyoo","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu-Mahn","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Deog","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","article-title":"Treating the whole body in Huntington\u2019s disease","volume":"14","author":"Carroll","year":"2015","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.2147\/dddt.s58470","article-title":"Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy","volume":"9","author":"Chang","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1038\/s41598-017-05709-y","article-title":"Defective sphingosine-1-phosphate metabolism is a druggable target in Huntington\u2019s disease","volume":"7","author":"Di Pardo","year":"","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fnins.2017.00698","article-title":"De novo synthesis of sphingolipids is defective in experimental models of Huntington\u2019s disease","volume":"11","author":"Di Pardo","year":"","journal-title":"Front. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Di Pardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fnins.2016.00457","article-title":"Impaired levels of gangliosides in the corpus callosum of Huntington disease animal models","volume":"10","author":"Di Pardo","year":"2016","journal-title":"Front. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/hmg\/ddy153","article-title":"Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington\u2019s disease","volume":"27","author":"Di Pardo","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.4103\/1673-5374.215253","article-title":"Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington\u2019s disease","volume":"12","author":"Di Pardo","year":"2017","journal-title":"Neural Regen. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tips.2018.02.009","article-title":"The S1P axis: new exciting route for treating Huntington\u2019s disease","volume":"39","author":"Di Pardo","year":"","journal-title":"Trends Pharmacol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fnins.2018.00249","article-title":"Sphingolipid metabolism: a new therapeutic opportunity for brain degenerative disorders","volume":"12","author":"Di Pardo","year":"","journal-title":"Front. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington\u2019s disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e64037","DOI":"10.1371\/journal.pone.0064037","article-title":"Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington\u2019s disease","volume":"8","author":"Giamp\u00e0","year":"2013","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1326-6-71","article-title":"Conditional BDNF release under pathological conditions improves Huntington\u2019s disease pathology by delaying neuronal dysfunction","volume":"6","author":"Giralt","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"B15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.12703\/p6-109","article-title":"S1P signaling: new therapies and opportunities","volume":"6","author":"Gonzalez-Cabrera","year":"2014","journal-title":"F1000Prime Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bbamem.2017.03.008","article-title":"Sphingosine 1-phosphate - A double edged sword in the brain","volume":"1859","author":"Karunakaran","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd4099","article-title":"Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond","volume":"12","author":"Kunkel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8518","DOI":"10.1074\/jbc.m506182200","article-title":"Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation","volume":"281","author":"Lavieu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1038\/ncomms6514","article-title":"Pathological roles of the VEGF\/SphK pathway in Niemann-Pick type C neurons","volume":"5","author":"Lee","year":"2014","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/s1388-1981(02)00132-4","article-title":"Sphingosine-1-phosphate and lipid phosphohydrolases","volume":"1582","author":"Le Stunff","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"B22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mad.2005.09.011","article-title":"Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington\u2019s disease mutation","volume":"127","author":"Maglione","year":"","journal-title":"Mech. Ageing Dev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neulet.2005.09.037","article-title":"The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington\u2019s disease patients with predominant chorea","volume":"393","author":"Maglione","year":"","journal-title":"Neurosci. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ajmg.b.30223","article-title":"Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington\u2019s disease","author":"Maglione","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","article-title":"Impaired ganglioside metabolism in Huntington\u2019s disease and neuroprotective role of GM1","volume":"30","author":"Maglione","year":"2010","journal-title":"J. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","article-title":"Autophagy in Huntington disease and huntingtin in autophagy","volume":"38","author":"Martin","year":"2015","journal-title":"Trends Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e4770","DOI":"10.1371\/journal.pone.0004770","article-title":"Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice","volume":"4","author":"Matamales","year":"2009","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e68951","DOI":"10.1371\/journal.pone.0068951","article-title":"The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients","volume":"8","author":"Metzger","year":"2013","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15407\/ubj85.01.005","article-title":"Sphingosine-1-phosphate: distribution, metabolism and role in the regulation of cellular functions","volume":"85","author":"Morozov","year":"2013","journal-title":"Ukr. Biokhim. Zh. (1999)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41419-018-0599-5","article-title":"Sphingosine kinase 1-associated autophagy differs between neurons and astrocytes","volume":"9","author":"Moruno-Manchon","year":"2018","journal-title":"Cell Death Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/hmg\/ddx046","article-title":"Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease","volume":"26","author":"Moruno-Manchon","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"15213","DOI":"10.1038\/srep15213","article-title":"Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy","volume":"5","author":"Moruno Manchon","year":"2015","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.3390\/cells6020014","article-title":"Methods for measuring autophagy in mice","volume":"6","author":"Moulis","year":"2017","journal-title":"Cells"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1194\/jlr.M900048-JLR200","article-title":"Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies","volume":"50","author":"O\u2019Brien","year":"2009","journal-title":"J. Lipid Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","article-title":"Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases","volume":"113","author":"O\u2019Sullivan","year":"2017","journal-title":"Neuropharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41467-017-00353-6","article-title":"Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements","volume":"8","author":"Pirhaji","year":"2017","journal-title":"Nat. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nmeth.3940","article-title":"Revealing disease-associated pathways by network integration of untargeted metabolomics","volume":"13","author":"Pirhaji","year":"2016","journal-title":"Nat. Methods"},{"key":"B41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The role of PI3K\/Akt and ERK in neurodegenerative disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"S\u00e1nchez","year":"2003","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ncb2987","article-title":"Coupling between endocytosis and sphingosine kinase 1 recruitment","volume":"16","author":"Shen","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11866","article-title":"Identification of a candidate therapeutic autophagy-inducing peptide","volume":"494","author":"Shoji-Kawata","year":"2013","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1212\/WNL.0b013e31820d9507","article-title":"The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators","volume":"76","author":"Soliven","year":"2011","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1083\/jcb.200510065","article-title":"Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway","volume":"172","author":"Yamamoto","year":"2006","journal-title":"J. Cell Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T04:47:26Z","timestamp":1556081246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":47,"alternative-id":["10.3389\/fnmol.2019.00100"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2019.00100","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"article-number":"100"}}